epidyolex - search results

GW Pharmaceuticals' Epidyolex has been rescheduled in the UK, making life easier for patients, healthcare professionals and pharmacists. Epidyolex, which is marketed as Epidiolex in...

GW Pharmaceuticals announced yesterday the United States Drug Enforcement Administration (DEA) has determined Epidiolex is no longer subject to the Controlled Substances Act (CSA),...

GW Pharmaceuticals (Nasdaq:GWPH) has posted better than expected results on the back of its cannabidiol-based medication Epidiolex. The company expects its total net product sales...

A new poll reveals 2.8% of the British adult population is using "street cannabis" for medicinal purposes - up to 1.4 million people. A survey...